FDA-Cleared Yōni.Fit Device Revolutionizes Women's Bladder and Menstrual Health

Watkins-Conti Products, Inc., a pioneering enterprise focused on advancing women's pelvic health, has announced a landmark expansion of the application for its innovative flagship device, the Yōni.Fit Bladder Support. This breakthrough represents the first FDA-approved dual-purpose vaginal insert that not only manages stress urinary incontinence (SUI) but also collects menstrual fluid and vaginal discharge, addressing a substantial unmet clinical need for active women experiencing these common yet often under-discussed conditions.

The Yōni.Fit device, constructed from 100% medical-grade silicone and manufactured entirely within the United States, is designed to be soft and flexible, facilitating comfortable self-insertion and removal. It is offered in six distinct sizes to accommodate variations in anatomy and is available either through healthcare provider prescription or directly online. This accessibility ensures broader reach and empowers women to manage their pelvic health proactively without the burden of invasive procedures or external devices.

Stress urinary incontinence-a condition characterized by involuntary urine leakage triggered by increased intra-abdominal pressure during activities such as physical exertion, coughing, or laughing-affects approximately two-thirds of women in the United States at some point in their lives. The impact on quality of life can be profound, influencing social engagement, psychological wellbeing, and even physical health. Prior to the Yōni.Fit, options for SUI were often limited to absorbent products that do not address the cause and can be inconvenient and uncomfortable. The Yōni.Fit's FDA clearance in 2024 for up to 12 hours of continuous use marked a significant advancement in non-invasive SUI management.

The recent FDA labeling expansion of Yōni.Fit is a game-changer in the realm of menstrual hygiene, particularly for women who also experience stress urinary incontinence. The device now officially supports the safe collection of menstrual fluid and vaginal discharge alongside managing bladder leakage during menstruation. This innovation aligns with increasing user interest in menstrual cups, which are gaining popularity for their eco-friendly profile, reusability, and cost-effectiveness. Harvard Chan School of Public Health research indicates that around 20% of menstruating women in the U.S. currently use menstrual cups, especially those aged 18 to 35.

Clinical evidence supporting Yōni.Fit's efficacy is robust, stemming from randomized, controlled, single-blind, multi-center trials involving women diagnosed with SUI. The device achieved over 96% reduction in clinically significant bladder leaks, underscoring its reliability and effectiveness as a pelvic health tool. Adverse effects reported were minor to moderate in severity, with no serious device-related complications, affirming Yōni.Fit's safety profile for everyday use.

Clinicians specializing in urogynecology and reconstructive pelvic surgery endorse the device's expanded utility. According to Dr. Karolynn Echols, a principal investigator in the clinical trials and Associate Professor at Thomas Jefferson University, Yōni.Fit offers patients a unique self-care option that extends beyond traditional incontinence products by integrating menstrual fluid management. Such dual functionality reduces reliance on disposable pads and tampons, which have detrimental environmental footprints.

Founder and CEO Allison L. Watkins emphasizes the longstanding demand from women for a versatile solution that addresses multiple leakages simultaneously. She highlights the device's role in advancing environmental sustainability while maintaining clinical efficacy and user comfort. Watkins-Conti's innovation underlines a trend toward patient-centered design in medical devices that deeply understand users' lived experiences.

Given the device's prescription status and inclusion in Health Savings Account (HSA) eligibility, Yōni.Fit may be covered under select insurance plans, improving affordability. Healthcare providers can easily integrate the device into their practice through specialized stocking options provided by Watkins-Conti, which supports a smooth prescribing and supply chain experience.

The company's strategic vision extends well beyond the Yōni.Fit, aiming to build a comprehensive pipeline of pelvic health innovations backed by a strong intellectual property portfolio. With multiple U.S. and international patents, Watkins-Conti is securing its position at the forefront of women's healthcare technologies, focused on delivering clinical solutions that are both accessible and effective.

In conclusion, the expanded FDA clearance of Yōni.Fit as both an SUI treatment and a menstrual fluid collector marks a significant milestone in female pelvic health innovation. This development not only enhances the quality of life for millions of women but also contributes to environmental sustainability and women's autonomy over their bodies. Offerings such as Yōni.Fit represent the next generation of pelvic health solutions, blending clinical sophistication with practical usability in everyday life.